Almitas Capital LLC Reduces Stake in CT Healthcare Trust Plc Below 5% Voting Rights Threshold

Overview of CT Healthcare Trust Plc and Healthcare Real Estate Sector

CT Healthcare Trust Plc, listed in the United Kingdom with ISIN GB00BZCNLL95, is an investment trust specializing in healthcare real estate. The company focuses on acquiring and managing healthcare properties, generating returns through rental income, capital growth, and dividends. The healthcare real estate sector has garnered strong institutional interest due to demographic trends driving sustained demand for healthcare facilities across developed markets.

Healthcare real estate investment trusts concentrate on assets such as hospitals, medical offices, care homes, and specialized healthcare infrastructure. These trusts offer investors exposure to the healthcare property market while typically providing dividend income. The sector benefits from its counter-cyclical nature, as demand for healthcare services persists regardless of economic cycles. CT Healthcare Trust’s strategy aligns with capturing value from evolving healthcare infrastructure needs.

Almitas Capital’s Voting Rights Decline from 6.82% to Below 5%

The regulatory notification dated 20 July 2026 confirms that Almitas Capital LLC has reduced its voting rights in CT Healthcare Trust Plc below the 5% threshold. This is a significant change from its earlier disclosed position of 6.82%, which was entirely held through financial instruments. The transaction causing this change was completed on 16 July 2026, with notification made within the required four trading days, in compliance with Financial Conduct Authority (FCA) rules.

Dropping below the 5% threshold removes Almitas Capital from the category of major shareholders subject to continuous enhanced disclosure obligations under the Disclosure Transparency Rules. Both direct and indirect voting rights now remain under 5%, with the financial instruments—previously comprising the full holding—substantially decreased. This suggests a strategic portfolio adjustment by the US-based investor, possibly reflecting a reassessment of its healthcare real estate exposure or broader investment objectives.

Use of Financial Instruments for Previous 6.82% Stake

Almitas Capital’s prior 6.82% voting rights position was held exclusively via financial instruments, including derivatives and contracts for difference (CFDs), rather than direct share ownership. This approach allows investors to gain economic and voting exposure without legal ownership of shares, a common tactic among sophisticated institutional investors managing concentrated holdings or capital efficiency.

The recent notification indicates that Almitas Capital continues to hold a position through cash-settled CFDs, though voting rights tied to these instruments have fallen below the 5% threshold. CFDs enable exposure to share price movements while offering flexibility in managing positions. The transaction’s completion in the United States on 16 July 2026 suggests the reduction was executed through existing derivative arrangements, reflecting the ease of adjusting such positions compared to outright share sales.

Regulatory Notification Timeline and Compliance

The notification was filed four days after the threshold-crossing transaction, on 20 July 2026, meeting FCA requirements for disclosure within four trading days. The transaction date of 16 July 2026 (a Wednesday) necessitated notification by the following Tuesday; the actual filing on Sunday aligns with procedural allowances for weekends and international time zones.

Almitas Capital LLC, registered in Santa Monica, California, is identified as the notifying party under the Disclosure Transparency Rules. The TR-1 form confirms Almitas Capital acts as both the acquirer/disposer and holder of voting rights. The ultimate controlling entity is Almitas Capital LLC itself, indicating no higher-tier control over voting decisions or position management. This clarifies that the investment choices were made directly by the Santa Monica-based firm without parent company intervention.

Structure of Almitas Capital’s Holding Reduction

The notification reveals that Almitas Capital LLC holds its position through a controlled undertaking bearing the same name, a structure typical for US-based investment entities. This arrangement shows the ultimate controlling entity and direct holding entity are identical, with no intermediate ownership layers. Such a simplified structure may be designed for tax efficiency or regulatory compliance in managing UK-listed securities.

The previous 6.82% stake was entirely composed of voting rights via financial instruments, with no direct share ownership. Post-transaction, the position remains below 5% across direct, indirect, and aggregate voting rights. The residual holding consists solely of CFDs subject to cash settlement, indicating a continued preference for derivative-based exposure over physical shares.

Transaction Execution in United States Jurisdiction

The disposal transaction was completed in the United States on 16 July 2026, reflecting Almitas Capital’s use of its domestic trading infrastructure rather than UK intermediaries. This practice is common among major US institutional investors participating in London-listed securities. The use of US brokers and custodians for execution and settlement underscores Almitas Capital’s operational base despite its investment in UK equities.

The filing and issuer notification occurred on 20 July 2026, adhering to the four-day regulatory window. This timeline is typical for cross-border transactions involving US-based parties, where additional settlement and documentation processes may extend notification to the maximum allowable period.

Implications for Investors and Shareholding Concentration

Almitas Capital’s reduction below the 5% reporting threshold may slightly decrease concentration among CT Healthcare Trust Plc’s major shareholders, potentially dispersing voting power more broadly. This shift could influence corporate governance, proxy voting outcomes, and the relative sway of remaining large investors. Market participants may watch for responses from other institutional holders adjusting to the evolving shareholder landscape.

The announcement offers no explicit explanation for the stake reduction or future plans regarding CT Healthcare Trust. The disposal might represent profit-taking, portfolio rebalancing within healthcare real estate, or a strategic shift. Retaining a sub-5% position through CFDs indicates Almitas Capital has not fully exited its interest in the trust.

Regulatory Filing and Disclosure Obligations

The TR-1 notification filed on 20 July 2026 complies with FCA Disclosure Transparency Rules, which require entities to report voting rights changes crossing thresholds such as 5%, 10%, 15%, and others. Almitas Capital’s downward crossing of the 5% mark triggered this mandatory disclosure, ensuring transparency for market participants.

The filing details the nature of voting rights, the financial instruments involved, and the ownership chain’s controlled undertakings. This information is accessible via the Regulatory News Service and FCA channels, enabling investors to analyze shareholding changes and intentions. CT Healthcare Trust Plc shareholders can use these disclosures to evaluate potential shifts in governance and major shareholder influence.

Market Reaction and Monitoring Recommendations

Public data does not clearly indicate immediate share price or trading volume impacts following the notification. Typically, reductions below the 5% threshold attract less market attention than increases above it, as they often signal exits rather than new commitments. Nonetheless, investors should observe CT Healthcare Trust’s share price and trading activity in subsequent days to gauge market response.

Going forward, investors should track whether Almitas Capital adjusts its remaining position further, how other major shareholders respond, and any management commentary on the transaction. Monitoring the overall major shareholder register will help assess whether ownership concentration is increasing or dispersing. Future voting rights notifications crossing key thresholds should be reviewed promptly for governance and strategic implications.